Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

No link between hair loss and blood groups or Rhesus factor.

The harlequin ichthyosis mouse mutation causes thick skin and early death, resembling a human skin disorder.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

EREG therapy may help treat hair loss by promoting hair growth.

New mutations in the hairless gene may cause hair loss and affect bone development.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Alopecia areata affects quality of life more in adolescents than adults.

Hematological ratios can effectively predict and manage alopecia areata severity.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Stem cell treatment can effectively regrow hair.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Lizard claws have hair-like keratins similar to those in mammals.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

THA is a rare condition with no significant clinical consequences if thyroid function is normal.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.